|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Nevro Corp.
| | | Phone: | (650) 251-0005 | Year Established: | 2007 | Ticker: | NVRO | Exchange: | NYSE | Main Contact: | Michael Enxing, VP, Sales and Marketing | | Other Contacts: | Patrick Schmitz, VP, Operations Andre Walker, Senior VP, R&D Michael Hall, General Counsel Bradford E. Gliner, VP, Clinical and Regulatory Affairs Richard B. Carter, VP, Finance, Corporate Controller Doug Alleavitch, VP, Quality David Caraway, MD, Ph.D., CMO Rami Elghandour, President Andrew Galligan, CFO Michael DeMane, Chairman & CEO
| | Company Description | Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The Senza system is the only SCS system that delivers Nevro's proprietary HF10 therapy. | |
|
|
|
|
|